Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce E Johnson

Showing results (51-60 of 284) with videos related to

Pageof 29
Sort By:
Journal of the National Cancer Institute|June 26, 2014
Evaluation of statistical designs in phase I expansion cohorts: the Dana-Farber/Harvard Cancer Center experienceSuzanne E Dahlberg, Geoffrey I Shapiro, Jeffrey W Clark, et al.
Lung Cancer (Amsterdam, Netherlands)|April 16, 2004
Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapyLori J Wirth, Mark R Carter, Pasi A Jänne, et al.
Cancer|July 2, 2003
Expression of bcl-2 protein is associated with shorter survival in nonsmall cell lung carcinomaChris I Huang, Donna Neuberg, Bruce E Johnson, et al.
Cancer Research|October 20, 2004
Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255Sean Tracy, Toru Mukohara, Mark Hansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
A metabolic study of patients with lung cancer and hyponatremia of malignancyJohn P Chute, Elizabeth Taylor, John Williams, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Molecular biology, genomics, and proteomics in bronchioloalveolar carcinomaMarie Wislez, David G Beer, Ignacio Wistuba, et al.
American Journal of Epidemiology|February 4, 2010
Parity and risk of lung cancer in womenJessica K Paulus, Kofi Asomaning, Peter Kraft, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 13, 2012
Everolimus and erlotinib as second- or third-line therapy in patients with advanced non-small-cell lung cancerVassiliki A Papadimitrakopoulou, Jean-Charles Soria, Annette Jappe, et al.
Lung Cancer (Amsterdam, Netherlands)|July 27, 2010
Haplotypes of estrogen receptor-beta and risk of non-small cell lung cancer in womenJessica K Paulus, Wei Zhou, Peter Kraft, et al.
Cancer|April 9, 2013
Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancerJunya Zhu, Dhruv B Sharma, Aileen B Chen, et al.
Pageof 29

Showing results (51-60 of 284) with videos related to

Sort By:
Pageof 29
Journal of the National Cancer Institute|June 26, 2014
Evaluation of statistical designs in phase I expansion cohorts: the Dana-Farber/Harvard Cancer Center experienceSuzanne E Dahlberg, Geoffrey I Shapiro, Jeffrey W Clark, et al.
Lung Cancer (Amsterdam, Netherlands)|April 16, 2004
Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapyLori J Wirth, Mark R Carter, Pasi A Jänne, et al.
Cancer|July 2, 2003
Expression of bcl-2 protein is associated with shorter survival in nonsmall cell lung carcinomaChris I Huang, Donna Neuberg, Bruce E Johnson, et al.
Cancer Research|October 20, 2004
Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255Sean Tracy, Toru Mukohara, Mark Hansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
A metabolic study of patients with lung cancer and hyponatremia of malignancyJohn P Chute, Elizabeth Taylor, John Williams, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Molecular biology, genomics, and proteomics in bronchioloalveolar carcinomaMarie Wislez, David G Beer, Ignacio Wistuba, et al.
American Journal of Epidemiology|February 4, 2010
Parity and risk of lung cancer in womenJessica K Paulus, Kofi Asomaning, Peter Kraft, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 13, 2012
Everolimus and erlotinib as second- or third-line therapy in patients with advanced non-small-cell lung cancerVassiliki A Papadimitrakopoulou, Jean-Charles Soria, Annette Jappe, et al.
Lung Cancer (Amsterdam, Netherlands)|July 27, 2010
Haplotypes of estrogen receptor-beta and risk of non-small cell lung cancer in womenJessica K Paulus, Wei Zhou, Peter Kraft, et al.
Cancer|April 9, 2013
Comparative effectiveness of three platinum-doublet chemotherapy regimens in elderly patients with advanced non-small cell lung cancerJunya Zhu, Dhruv B Sharma, Aileen B Chen, et al.
Pageof 29